Abiopharma

🔍 Pardo Ryan (Executive)

Company: LifeStance Health Group, Inc. (LFST)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 129,496 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: false | shares_owned_after: 1,045,231.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 21,854 shares of Common Stock at $6.93 per share (Direct)
  Date: 2026-03-06 | Code: F | equity_swap_involved: false | shares_owned_after: 1,023,377.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,551,520.00 | Footnotes: F3

Footnotes:

• F1: Includes 129,496 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• F2: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
• F3: Shares held of record by Kimberly Pardo Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose.
• REMARKS: Chief Legal Officer and Secretary